Aclaris Therapeutics to Participate in the Leerink Partners 2026 Global Healthcare Conference

Core Insights - Aclaris Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing novel product candidates for immuno-inflammatory diseases [3] - The company will participate in a fireside chat at the Leerink Partners 2026 Global Healthcare Conference on March 10, 2026 [1] - A live and archived webcast of the event will be available on Aclaris' website for at least 30 days [2] Company Overview - Aclaris Therapeutics is developing a pipeline of product candidates aimed at addressing the needs of patients with immuno-inflammatory diseases who currently lack satisfactory treatment options [3] - The company boasts a multi-stage portfolio of product candidates supported by a robust research and development engine [3]